Navigation Links
RWD Announces Investments In Growing Health Care Practice
Date:4/15/2009

Increased Efforts to Assist Hospitals Managing Merger of Economic and Health Care Crises

BALTIMORE, April 15 /PRNewswire/ -- RWD Technologies, LLC (RWD), a global company that develops and implements human and organizational performance solutions, today announced a multimillion-dollar investment in its growing health care practice. The investment includes the engagement of various stakeholders about process improvements that save money and free up time for measurably better care. A key component of this effort is the signing of Michael Jhin, a 30-year hospital veteran, as an executive advisor to lead discussions throughout the hospital industry about the role that operational excellence can play to help meet the challenges hospitals face.

As part of RWD's investment, the company is developing the Lean Learning Academy, a tailored program designed to engage, empower and equip hospital executives, managers, supervisors and others in transitioning into a more efficient environment that focuses on collaborative solutions to everyday challenges.

In addition, RWD is increasing its ongoing advocacy and education efforts through strategic partnerships with the American Hospital Association, Maryland Hospital Association and Health Forum, an outlet that provides information to enhance the capacity of health care leaders to improve community health and business performance. To augment these efforts, RWD has contracted Edelman, a leading strategic public relations firm to increase awareness of the company's work in health care.

"Hospitals are at the crossroads of both the economic and financial challenges we're facing. With Jhin's experience and industry knowledge, RWD is able to help hospital CEOs face these challenges through proven approaches to process improvement that save money and give precious time back to hospital workers," said Jim Parish, executive vice president, Energy Solutions
'/>"/>

SOURCE RWD Technologies, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide
2. Washington State Nurses Association Announces Formation of a New National Nurses Union
3. Cynosure Announces Preliminary Financial Results for the First Quarter of 2009
4. Leading Clinical Technology Organization M2S Inc. Announces the Appointment of Jeffrey Yablon as Senior Vice President, Business Development
5. Telik Announces Preclinical Presentations at AACR Annual Meeting
6. NuVasive Announces Conference Call and Webcast of First Quarter 2009 Results
7. NHP Announces First Quarter Earnings Release Date and Webcast/ Conference Call
8. TeamHealth Announces Nine New Contracts in First Quarter 2009
9. Intrinsic Therapeutics Announces CE Mark for Barricaid Anular Prosthesis
10. Health Alliance Announces First Fracture Protection Program for Actonel(R) (risedronate sodium) Tablets
11. Rochester Medical Announces Second Quarter 2009 Earnings Conference Call April 30, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Sanofi Aventis 3A Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes 4919 1Sanofi Aventis 3A Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes 4919 2Sanofi Aventis 3A Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes 4919 3Sanofi Aventis 3A Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes 4919 4Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 1Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 2Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 3Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 4Abbott Launches Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent in International Markets 55665 1Abbott Launches Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent in International Markets 55665 2Abbott Launches Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent in International Markets 55665 3Abbott Launches Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent in International Markets 55665 4Abbott Launches Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent in International Markets 55665 5